Edgewise Therapeutics, Inc. (EWTX)
28.35
-0.53
(-1.84%)
USD |
NASDAQ |
Mar 05, 16:00
28.35
0.00 (0.00%)
After-Hours: 19:31
Edgewise Therapeutics Cash from Investing (Quarterly) : 49.76M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Glaukos Corp. | -15.89M |
| Nuvalent, Inc. | -280.94M |
| Neurocrine Biosciences, Inc. | -52.90M |
| Omeros Corp. | -6.861M |
| Agios Pharmaceuticals, Inc. | 90.08M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -38.59M |
| Cash from Financing (Quarterly) | 3.975M |
| Free Cash Flow | -144.07M |
| Free Cash Flow Per Share (Quarterly) | -0.3647 |
| Free Cash Flow to Equity (Quarterly) | -38.47M |
| Free Cash Flow to Firm (Quarterly) | -38.66M |
| Free Cash Flow Yield | -4.94% |